Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
techcrunch.comAisha Malik
Science Corporation completed its first implant of a vision-restoring chip in a patient with Stargardt disease, marking progress in retinal implant technology. The procedure represents advancement in brain-computer interfaces, with involvement from Max Hodak, former Neuralink co-founder.
Why it mattersThis demonstrates practical application of neural implant technology beyond research, showing viable paths for AI-assisted medical devices to restore sensory function in patients with degenerative conditions.
From the source: Max Hodak, the former president and co-founder of Neuralink, detailed on stage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).Read at techcrunch.com